The nccn guidelines for prostate cancer provide a framework on which to base decisions regarding the workup of patients with prostate cancer, risk stratification and management of localized disease, รขโ‚ฌยฆ Metastatic castration-sensitive prostate cancer (cspc) can be treated with hormone therapy, radiation therapy and chemotherapy. Prostate cancer is the most common tumor in men.

Introduction treatment of metastatic castrate-sensitive prostate cancer (mcspc) has evolved dramatically over the past 20 years. In the early 21st century, treatment of advanced prostate cancer รขโ‚ฌยฆ